After 12 months of TRE, body mass was reduced by 3.4% and inflammatory markers (IL-6, IL-1β, and TNF-α), lipid profile (HDL, LDL, TG), and insulin resistance (fasting glucose, insulin, HOMA-IR) significantly improved compared with ND without affecting muscle performance. This evidence concerns the gene IL1B and Insulin resistance.